LENZ Therapeutics, Inc. (LENZ): Free Cash Flow
-$70.00M
Year ended 2025-12-31
-$114.42M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$70.00M | n/m | 2026-03-24, From 2025-01-01 |
| 2024-12-31 | -$59.86M | n/m | 2026-03-24, From 2024-01-01 |
| 2023-12-31 | -$60.41M | n/c | 2025-03-19, From 2023-01-01 |
| 2022-12-31 | -$94.57M | n/m | 2024-02-27, From 2022-01-01 |
| 2021-12-31 | -$58.59M | n/m | 2023-03-20, From 2021-01-01 |
| 2020-12-31 | -$10.27M | n/a | 2022-03-21, From 2020-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| LENZ Therapeutics, Inc. (LENZ) | 2025-12-31 | -$70.00M | n/m |
| Alector, Inc. (ALEC) | 2025-12-31 | -$184.07M | n/m |
| Pelthos Therapeutics Inc. (PTHS) | 2025-12-31 | -$22.69M | n/m |
| Relay Therapeutics, Inc. (RLAY) | 2025-12-31 | -$235.87M | n/m |
| Lineage Cell Therapeutics, Inc. (LCTX) | 2025-12-31 | -$19.44M | n/m |
| Metagenomi Therapeutics, Inc. (MGX) | 2025-12-31 | -$89.47M | n/m |
| Scilex Holding Co (SCLX) | 2025-12-31 | $3.68M | -81.0% |
| Caribou Biosciences, Inc. (CRBU) | 2025-12-31 | -$112.35M | n/m |
| Precision Biosciences Inc (DTIL) | 2025-12-31 | -$65.93M | n/m |
Compare LENZ, ALEC, PTHS, RLAY side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗